CVR: 46354125
Selskabets formål er at udvikle lægemidler til behandling af ultra-sjældne sygdomme.
Stephanie Manton joined as director
Stephanie Manton registered with 50% ownership
ACRI INVEST ApS registered with 33% ownership
registered with 5% ownership
was founded
Companies in the same industry and area
CVR 31940427
CVR 45664872
CVR 31981034
CVR 45078248
CVR 42773883
companydata.dk